Schäffler L, Imbach P, Rüdeberg A, Vassella F, Karbowski K
Neuropsychobiology. 1984;11(1):65-71. doi: 10.1159/000118054.
106 EEG investigations were carried out in 17 children with various types of neoplastic disease without cerebral involvement during one or more courses of treatment with cytotoxic agents. EEGs were recorded before and 24 h after administration of the drugs. A transient slowing of the dominant frequency in the alpha-band by about 1 c/s and a decrease in the relative power of alpha-activity by 20-30% was observed in only 4 patients. These children did not receive the same antineoplastic treatment. 1 patient received very high dose methotrexate, 2 patients received vincristine combined with other cytotoxic agents, and the other patient received L-asparaginase. It is suggested that EEG changes in patients receiving intravenous cytotoxic treatment usually occur only where there is a preexisting impairment of the blood-cerebrospinal fluid barrier or the blood-brain barrier.
对17名患有各种类型肿瘤疾病且无脑转移的儿童进行了106次脑电图检查,这些检查在细胞毒性药物的一个或多个疗程治疗期间进行。在给药前和给药后24小时记录脑电图。仅在4名患者中观察到α波段的主导频率短暂减慢约1赫兹,α活动的相对功率降低20%-30%。这些儿童接受的抗肿瘤治疗不同。1名患者接受了非常高剂量的甲氨蝶呤,2名患者接受了长春新碱与其他细胞毒性药物联合治疗,另一名患者接受了L-天冬酰胺酶治疗。提示接受静脉细胞毒性治疗的患者脑电图改变通常仅发生在血脑屏障或血脑脊液屏障预先存在损害的情况下。